Cargando…
Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study
OBJECTIVE: The benefits of real-time continuous glucose monitoring (CGM) have been demonstrated in patients with type 1 diabetes. Our aim was to compare the effect of two modes of use of CGM, patient led or physician driven, for 1 year in subjects with poorly controlled type 1 diabetes. RESEARCH DES...
Autores principales: | Riveline, Jean-Pierre, Schaepelynck, Pauline, Chaillous, Lucy, Renard, Eric, Sola-Gazagnes, Agnès, Penfornis, Alfred, Tubiana-Rufi, Nadia, Sulmont, Véronique, Catargi, Bogdan, Lukas, Céline, Radermecker, Régis P., Thivolet, Charles, Moreau, François, Benhamou, Pierre-Yves, Guerci, Bruno, Leguerrier, Anne-Marie, Millot, Luc, Sachon, Claude, Charpentier, Guillaume, Hanaire, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329830/ https://www.ncbi.nlm.nih.gov/pubmed/22456864 http://dx.doi.org/10.2337/dc11-2021 |
Ejemplares similares
-
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen
por: Franc, Sylvia, et al.
Publicado: (2020) -
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial
por: Jeandidier, Nathalie, et al.
Publicado: (2018) -
No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial
por: Franc, Sylvia, et al.
Publicado: (2021) -
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA(1c) in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)
por: Charpentier, Guillaume, et al.
Publicado: (2011) -
Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study
por: Raccah, Denis, et al.
Publicado: (2009)